GTCR and ex-NuVasive chief launch Corza Medical via two-part deal

GTCR and former NuVasive CEO launched Corza Medical by acquiring Surgical Specialties and merging it with TachoSil, a carve-out from Takeda, creating a surgical technologies company with over $300 million in revenue.

“Corza Medical snaps up Surgical Specialties and merges it with TachoSil – a carve-out from Japan's Takeda – to create a $300 million-plus revenue generating surgical technologies company.”pehub.com

• 2 sources
• pehub.comGTCR and ex-NuVasive chief launch Corza Medical through two-part surgical technology deal | PE HubSarah PringleFeb 1, 2021
• corza.comGTCR and Gregory T. Lucier Announce Merger of Surgical Specialties and TachoSil to Create Corza Medical - Corza MedicalFeb 1, 2021

Summarized from public sources; check the original articles before acting on it.